financetom
Business
financetom
/
Business
/
Pfizer Says Braftovi Drug Combination Showed 'Significant' Improvement in Colorectal Cancer Trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer Says Braftovi Drug Combination Showed 'Significant' Improvement in Colorectal Cancer Trial
Mar 11, 2026 4:20 AM

08:14 AM EST, 02/17/2026 (MT Newswires) -- Pfizer ( PFE ) on Tuesday reported positive results from a trial evaluating Braftovi in combination with cetuximab and Folfiri in patients with previously untreated metastatic colorectal cancer.

The regimen showed a "statistically significant and clinically meaningful" improvement in progression-free survival, a key secondary endpoint, Pfizer ( PFE ) said. Overall survival, a descriptive secondary endpoint, also showed "clinically meaningful prolonged improvement," the drug maker said.

Detailed results will be shared with the US Food and Drug Administration to support the potential approval of the drug combination, Pfizer ( PFE ) said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
United Wolfram becomes largest Indian company to supply tungsten intermediates
United Wolfram becomes largest Indian company to supply tungsten intermediates
Feb 20, 2023
United Wolfram, an international metallurgical firm, has opened a new facility in Gujarat, becoming the largest Indian company to supply...
EY Entrepreneur of The Year Award 2023 Highlights: JSW head Sajjan Jindal wins coveted title
EY Entrepreneur of The Year Award 2023 Highlights: JSW head Sajjan Jindal wins coveted title
Feb 23, 2023
The EY Entrepreneur Of The Year program honors visionary entrepreneurs who shape our world, fuel economic growth, and stop at nothing to achieve their greatest ambitions. Every year, an independent jury comprising of some of India’s most eminent business leaders select the finalists and winners of the program. The EOY title winners include some of the most influential and recognizable names across the globe — Falguni Nayar, NR Narayana Murthy, Kumar Mangalam Birla, to name a few. With an impressive list of these past winners, the 24 edition promises to unveil more exceptional stories of innovation, resilience, and success. Join us for our live coverage of the glittering awards ceremony on 23 February 2023 at 7PM.
Macro uncertainty makes it a tough year for deal making, say top private equity investors
Macro uncertainty makes it a tough year for deal making, say top private equity investors
Feb 23, 2023
On the flip side, the dry powder with the investor community will give them the ability to provide growth capital for the companies when fund raising is challenging due to interest rate hike and volatile equity markets.
How small and mid-sized Indian ad agencies find their mojo, and grow
How small and mid-sized Indian ad agencies find their mojo, and grow
Feb 22, 2023
Independent creative shops stay away from pitches if they do not get paid for the time and effort they put into developing strategies and creatives.
Copyright 2023-2026 - www.financetom.com All Rights Reserved